Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 286144011000036111 | efalizumab 125 mg injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 286145011000036110 | efalizumab 125 mg injection, 125 mg vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| efalizumab 125 mg injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| efalizumab 125 mg injection, vial | Is a | efalizumab | true | Inferred relationship | Some | ||
| efalizumab 125 mg injection, vial | has intended active ingredient | efalizumab | true | Inferred relationship | Some | 989817920 | |
| efalizumab 125 mg injection, vial | has Australian BoSS | efalizumab | true | Inferred relationship | Some | 989817920 | |
| efalizumab 125 mg injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| efalizumab 125 mg injection, vial | has unit of use | vial | true | Inferred relationship | Some | 989817921 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Raptiva (efalizumab 125 mg) powder for injection, 125 mg vial | Is a | True | efalizumab 125 mg injection, vial | Inferred relationship | Some | |
| efalizumab 125 mg injection [4 vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack | has MPUU | True | efalizumab 125 mg injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Medicinal product unit of use reference set
FHIR